| Title： | Clinical Application Guidelines on Chinese Patent Medicine In the Treatment for Rheumatoid arthritis |
| Edition： | Original |
| Classification： | Traditional Chinese Medicine guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Western medicine specialists, general practitioners, clinical pharmacology and nursing staff in general hospitals who want to use Chinese patent medicine to treat rheumatoid patients. |
| Evidence classification method： | GRADE:The Grade of Recommendation，Assessment，Development and Evaluation |
| Development unit： | China Association of Traditional Chinese Medicine |
| Registration time: | 2022-11-22 |
| Registration number： | PREPARE-2022CN765 |
| Purpose of the guideline: | The compilation of Clinical Application Guidelines on Chinese Patent Medicine In the Treatment for Rheumatoid arthritis aims to standardize and promote the application of Chinese patent drugs in the treatment of rheumatoid arthritis, improve the treatment level of rheumatoid arthritis and reduce the burden of disease. |
